Antibody data
- Antibody Data
 - Antigen structure
 - References [0]
 - Comments [0]
 - Validations
 - Western blot [1]
 - Immunocytochemistry [1]
 - Immunohistochemistry [1]
 - Flow cytometry [1]
 
Submit
Validation data
Reference
Comment
Report error
- Product number
 - ARG55425 - Provider product page

 - Provider
 - Arigo
 - Product name
 - anti-AHSG antibody
 - Antibody type
 - Polyclonal
 - Antigen
 - KLH-conjugated synthetic peptide around aa. 247-276 (C-terminus) of Human AHSG.
 - Description
 - Purification with Protein A and immunogen peptide.
 - Reactivity
 - Human
 - Host
 - Rabbit
 - Isotype
 - IgG
 - Vial size
 - 100 µl
 - Storage
 - For continuous use, store undiluted antibody at 2-8°C for up to 1-2 weeks. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles.
 - Handling
 - The antibody solution should be gently mixed before use.
 
				No comments: Submit comment	
	
			
							
					Supportive validation
					
									
				
				- Submitted by
 - Arigo (provider)
 - Main image
 
- Experimental details
 - Western blot: 35 µg of Human blood plasma and liver tissue lysates (from left to right) stained with ARG55425 anti-AHSG antibody at 1:1000 dilution.
 
							
					Supportive validation
					
									
				
				- Submitted by
 - Arigo (provider)
 - Main image
 
- Experimental details
 - Immunofluorescence: HepG2 cell stained with ARG55425 anti-AHSG antibody (green). DAPI was used to stain the cell nuclear (blue).
 
							
					Supportive validation
					
									
				
				- Submitted by
 - Arigo (provider)
 - Main image
 
- Experimental details
 - Immunohistochemistry: formalin-fixed and paraffin-embedded Human hepatocarcinoma stained with ARG55425 anti-AHSG antibody.
 
							
					Supportive validation
					
									
				
		- Submitted by
 - Arigo (provider)
 - Main image
 
- Experimental details
 - Flow Cytometry: HepG2 cells stained with ARG55425 anti-AHSG antibody (right histogram) or without primary antibody control (left histogram), followed by incubation with FITC labelled secondary antibody.